Patents by Inventor Elisabeth Weiss

Elisabeth Weiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9084888
    Abstract: A method of determining a model of a marker includes obtaining projection images, each of the projection images having an image of a marker that indicates a shape of the marker, determining binary images of the marker for respective ones of the projection images, and constructing a three-dimensional model of the marker using the binary images, the three-dimensional model comprising a set of voxels in a three-dimensional space that collectively indicates a three-dimensional shape of the marker, wherein the act of constructing the three-dimensional model is performed using a processing unit.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: July 21, 2015
    Assignee: Varian Medical Systems, Inc.
    Inventors: Per Rugaard Poulsen, Walther Fledelius, Paul Keall, Elisabeth Weiss, Jun Lu, Emily Brackbill, Geoffrey Hugo
  • Publication number: 20130121551
    Abstract: A method of determining a model of a marker includes obtaining projection images, each of the projection images having an image of a marker that indicates a shape of the marker, determining binary images of the marker for respective ones of the projection images, and constructing a three-dimensional model of the marker using the binary images, the three-dimensional model comprising a set of voxels in a three-dimensional space that collectively indicates a three-dimensional shape of the marker, wherein the act of constructing the three-dimensional model is performed using a processing unit.
    Type: Application
    Filed: November 10, 2011
    Publication date: May 16, 2013
    Inventors: Per Rugaard Poulsen, Walther Fledelius, Paul Keall, Elisabeth Weiss, Jun Lu, Emily Brackbill, Geoffrey Hugo
  • Patent number: 8340247
    Abstract: A deliverable four dimensional (4D) intensity modulated radiation therapy (IMRT) planning method is disclosed, for delivery using a linear accelerator with a dynamic multi-leaf collimator (DMLC). A 4D computed tomography (CT) scan is used for segmenting tumor anatomy on a reference phase of periodic motion of the tumor. Deformable registration of the 4D CT data is used to generate corresponding anatomical structures on other phases. Preferably, the collimator for each beam position is aligned using the gross tumor volume (GTV) centroid motion corresponding to the periodic motion of the tumor, as determined from the two dimensional (2D) projection of a given beam position. A deliverable IMRT plan is created on the 4D CT image set in which the MLC leaf positions and beam on/off status can vary as a function of respiratory phase by solving a four dimensional optimization problem. The mechanical constraints of the MLC leaves are included in the optimization.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: December 25, 2012
    Assignee: Stanford University
    Inventors: Paul J. Keall, Yelin Suh, Elisabeth Weiss
  • Patent number: 8142772
    Abstract: This invention is directed to therapeutic compositions containing non-MHC-restricted Tcells/NK-cells in combination with MHC-restricted T-cells and especially to therapeutic compositions, which comprise LAK cells. Furthermore, the present invention is directed to the use of the above combination in the treatment of tumors in humans, which tumors show a missing, low or aberrant expression of MHC class Ia or Ib molecules. By using the aforementioned compositions/combinations it is possible to provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection.
    Type: Grant
    Filed: April 22, 2010
    Date of Patent: March 27, 2012
    Assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
    Inventors: Elfriede Noessner, Elisabeth Weiss, Dolores Schendel, Christine Falk
  • Publication number: 20110081002
    Abstract: A deliverable four dimensional (4D) intensity modulated radiation therapy (IMRT) planning method is disclosed, for delivery using a linear accelerator with a dynamic multi-leaf collimator (DMLC). A 4D computed tomography (CT) scan is used for segmenting tumor anatomy on a reference phase of periodic motion of the tumor. Deformable registration of the 4D CT data is used to generate corresponding anatomical structures on other phases. Preferably, the collimator for each beam position is aligned using the gross tumor volume (GTV) centroid motion corresponding to the periodic motion of the tumor, as determined from the two dimensional (2D) projection of a given beam position. A deliverable IMRT plan is created on the 4D CT image set in which the MLC leaf positions and beam on/off status can vary as a function of respiratory phase by solving a four dimensional optimization problem. The mechanical constraints of the MLC leaves are included in the optimization.
    Type: Application
    Filed: November 16, 2010
    Publication date: April 7, 2011
    Inventors: Paul J. Keall, Yelin Suh, Elisabeth Weiss
  • Patent number: 7835493
    Abstract: A deliverable four dimensional (4D) intensity modulated radiation therapy (IMRT) planning method is disclosed, for delivery using a linear accelerator with a dynamic multi-leaf collimator (DMLC). A 4D computed tomography (CT) scan is used for segmenting tumor anatomy on a reference phase of periodic motion of the tumor. Deformable registration of the 4D CT data is used to generate corresponding anatomical structures on other phases. Preferably, the collimator for each beam position is aligned using the gross tumor volume (GTV) centroid motion corresponding to the periodic motion of the tumor, as determined from the two dimensional (2D) projection of a given beam position. A deliverable IMRT plan is created on the 4D CT image set in which the MLC leaf positions and beam on/off status can vary as a function of respiratory phase by solving a four dimensional optimization problem. The mechanical constraints of the MLC leaves are included in the optimization.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: November 16, 2010
    Assignee: Stanford University
    Inventors: Paul J. Keall, Yelin Suh, Elisabeth Weiss
  • Publication number: 20100203086
    Abstract: This invention is directed to therapeutic compositions containing non-MHC-restricted Tcells/NK-cells in combination with MHC-restricted T-cells and especially to therapeutic compositions, which comprise LAK cells. Furthermore, the present invention is directed to the use of the above combination in the treatment of tumors in humans, which tumors show a missing, low or aberrant expression of MHC class Ia or Ib molecules. By using the aforementioned compositions/combinations it is possible to provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection.
    Type: Application
    Filed: April 22, 2010
    Publication date: August 12, 2010
    Inventors: Elfriede Noessner, Elisabeth Weiss, Dolores Schendel, Christine Falk
  • Patent number: 7731950
    Abstract: This invention is directed to therapeutic compositions containing non-MHC-restricted T-cells/NK-cells in combination with MHC-restricted T-cells and especially to therapeutic compositions, which comprise LAK cells. Furthermore, the present invention is directed to the use of the above combination in the treatment of tumors in humans, which tumors show a missing, low or aberrant expression of MHC class 1a or 1b molecules. By using the aforementioned compositions/combinations it is possible to provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: June 8, 2010
    Assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
    Inventors: Elfriede Noessner, Elisabeth Weiss, Dolores Schendel, Christine Falk
  • Publication number: 20090041188
    Abstract: A deliverable four dimensional (4D) intensity modulated radiation therapy (IMRT) planning method is disclosed, for delivery using a linear accelerator with a dynamic multi-leaf collimator (DMLC). A 4D computed tomography (CT) scan is used for segmenting tumor anatomy on a reference phase of periodic motion of the tumor. Deformable registration of the 4D CT data is used to generate corresponding anatomical structures on other phases. Preferably, the collimator for each beam position is aligned using the gross tumor volume (GTV) centroid motion corresponding to the periodic motion of the tumor, as determined from the two dimensional (2D) projection of a given beam position. A deliverable IMRT plan is created on the 4D CT image set in which the MLC leaf positions and beam on/off status can vary as a function of respiratory phase by solving a four dimensional optimization problem. The mechanical constraints of the MLC leaves are included in the optimization.
    Type: Application
    Filed: August 6, 2008
    Publication date: February 12, 2009
    Inventors: Paul J. Keall, Yelin Suh, Elisabeth Weiss
  • Publication number: 20030095955
    Abstract: This invention is directed to therapeutic compositions containing non-MHC-restricted T-cells/NK-cells cells/NK-cells in combination with MHC-restricted T-cells and especially to therapeutic compositions, which comprise LAK cells. Furthermore, the present invention is directed to the use of the above combination in the treatment of tumors in humans, which tumors show a missing, low or aberrant expression of MHC class 1a or 1b molecules. By using the aforementioned compositions/combinations it is possible to provide a balanced selective pressure against emergence of tumor cell variants that would otherwise escape immune detection.
    Type: Application
    Filed: July 5, 2002
    Publication date: May 22, 2003
    Inventors: Elfriede Noessner, Elisabeth Weiss, Dolores Schendel, Christine Falk
  • Patent number: 6338950
    Abstract: The invention concerns a new immunoregulatory protein LST-1, nucleic acd sequences coding for this protein, a process for the isolation of this protein, as well as its use for the production of a therapeutic agent. The DNA and protein sequences are shown in SEQ ID NO:1 to 4.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: January 15, 2002
    Assignee: Roche Diagnostics GmbH
    Inventor: Elisabeth Weiss